1. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev. 1997. 10:694–719.
2. Watt G, Parola P. Scrub typhus and tropical rickettsioses. Curr Opin Infect Dis. 2003. 16:429–436.
3. Sheehy TW, Hazlett D, Turk RE. Scrub typhus: a comparison of chloramphenicol and tetracycline in its treatment. Arch Intern Med. 1973. 132:77–80.
4. Rajapakse S, Rodrigo C, Fernando SD. Drug treatment of scrub typhus. Trop Doct. 2011. 41:1–4.
5. Song JH, Lee C, Chang WH, Choi SW, Choi JE, Kim YS, Cho SR, Ryu J, Pai CH. Short-course doxycycline treatment versus conventional tetracycline therapy for scrub typhus: a multicenter randomized trial. Clin Infect Dis. 1995. 21:506–510.
6. Kim YS, Yun HJ, Shim SK, Koo SH, Kim SY, Kim S. A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. Clin Infect Dis. 2004. 39:1329–1335.
7. Watt G, Kantipong P, Jongsakul K, Watcharapichat P, Phulsuksombati D, Strickman D. Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial. Lancet. 2000. 356:1057–1061.
8. Tsai CC, Lay CJ, Wang CL, Ho YH, Wang LS, Chen LK. Levofloxacin versus tetracycline antibiotics for the treatment of scrub typhus. Int J Infect Dis. 2010. 14:e62–e67.
9. Oh SY, Chung MH, Oh SJ, Son MS, Ahn SW. An open clinical trial to compare the efficacy of ciprofloxacin, pefloxacin, and doxycycline in the treatment of scrub typhus. Korean J Infect Dis. 1995. 27:193–198.
10. Botelho-Nevers E, Rovery C, Richet H, Raoult D. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect. J Antimicrob Chemother. 2011. 66:1821–1830.
11. Tantibhedhyangkul W, Angelakis E, Tongyoo N, Newton PN, Moore CE, Phetsouvanh R, Raoult D, Rolain JM. Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi. Int J Antimicrob Agents. 2010. 35:338–341.
12. Kim DM, Kim HL, Park CY, Yang TY, Lee JH, Yang JT, Shim SK, Lee SH. Clinical usefulness of eschar polymerase chain reaction for the diagnosis of scrub typhus: a prospective study. Clin Infect Dis. 2006. 43:1296–1300.
13. Chang WH. Current status of tsutsugamushi disease in Korea. J Korean Med Sci. 1995. 10:227–238.
14. Jeong HW, Choi YK, Baek YH, Seong MH. Phylogenetic analysis of the 56-kDa type-specific protein genes of Orientia tsutsugamushi in Central Korea. J Korean Med Sci. 2012. 27:1315–1319.
15. Cracco C, Delafosse C, Baril L, Lefort Y, Morelot C, Derenne JP, Bricaire F, Similowski T. Multiple organ failure complicating probable scrub typhus. Clin Infect Dis. 2000. 31:191–192.
16. Jensenius M, Montelius R, Berild D, Vene S. Scrub typhus imported to Scandinavia. Scand J Infect Dis. 2006. 38:200–202.
17. Jee HG, Chung MH, Lee SG, Kim IS, Chang WH. Transmission of scrub typhus by needlestick from a patient receiving pefloxacin. Scand J Infect Dis. 1996. 28:411–412.
18. Raoult D, Roussellier P, Galicher V, Perez R, Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother. 1986. 29:424–425.
19. McClain JB, Joshi B, Rice R. Chloramphenicol, gentamicin, and ciprofloxacin against murine scrub typhus. Antimicrob Agents Chemother. 1988. 32:285–286.
20. Maurin M, Raoult D. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii. J Antimicrob Chemother. 1997. 39:725–730.
21. Botelho-Nevers E, Edouard S, Leroy Q, Raoult D. Deleterious effect of ciprofloxacin on Rickettsia conorii-infected cells is linked to toxin-antitoxin module up-regulation. J Antimicrob Chemother. 2012. 67:1677–1682.